Anson Funds Restructures Notes, Consents to $2 ATM Offering
NXAT sits 19% above its 52-week low of $0.801.
Summary
Nexus Advanced Technologies reached a restructuring agreement with Anson Funds covering its outstanding notes and warrants, named the ATM Consent, Note Repayment and Warrant Exchange Agreement dated October 2, 2026, and announced October 5, 2026. Anson consented to an at-the-market offering with a minimum price of $2 per share, well above the current $0.95 stock price, for the period from the week of September 28, 2026, through March 31, 2027. Upon payment of $2,500,000, the notes become convertible solely at a fixed price equal to the three-day VWAP preceding payment, and all anti-dilution, price reset and ratchet provisions terminate. The agreement also amends the warrants to permit cashless exchange using an exchange ratio of 0.5415, with a total of 4,500,000 ordinary shares issuable upon exchange, allocated 3,510,000 shares to Anson Investments Master Fund L.P. and 990,000 shares to Anson East Master Fund L.P. The cashless exchange provides no cash proceeds to the company and will dilute existing shareholders. The holder agrees to a volume limitation of 15% of daily Nasdaq trading volume for exchange shares or note conversion shares, which terminates upon uncured company defaults or Nasdaq trading suspension for over five days. This follows the company's recent auditor change and going concern disclosure. The agreement removes a potential overhang and signals lender support, but the ATM consent at a premium price may be difficult to execute given current trading levels.
Updated with an SEC 6-K filing · What changed
Updates
· SEC 6-K — Upon payment of $2,500,000, the Note becomes convertible solely at a fixed price equal to the three-day VWAP preceding payment, and all anti-dilution, price reset and ratchet provisions terminate.
- Note Conversion Terms
- Senior Secured Convertible Notes are due July 12, 2027.
- Once Note principal falls below $500,000, the Variable Rate Transaction prohibition in Section 4.12 is waived.
- Participation rights under Section 4.19 continue for 10 months after Note principal falls below $500,000.
- ATM Consent
- ATM consent period is from week of September 28, 2026, through March 31, 2027.
- Holder waives Variable Rate Transaction prohibition (SPA Section 4.12(b)) and participation right (SPA Section 4.19) for ATM sales.
- ATM consent is suspended if Company materially defaults on payment or delivery obligations for five business days.
- Company must pay Holder 20% of net ATM proceeds (after commissions/expenses) within three business days of settlement.
- Holder applies ATM payments first to accrued interest and late fees, then to principal.
- Unpaid ATM payments bear 8% annual interest from the third business day after the due date.
- ATM payments are allocated pro rata between Holder Funds based on Note principal.
- ATM payments must include a statement of shares sold, proceeds, commissions, and expenses.
- ATM Payments are in addition to, and not in substitution for, Holder's rights under Section 9 of the Note, which continue to apply to any private placement financing, Change of Control Transaction or other event described therein.
- The ATM offering is conducted pursuant to the Company's effective Form F-3 registration statement and a sales agreement with its sales agent.
- The Holder acknowledges the ATM may be delayed, suspended or terminated for legal, market or operational reasons, and the Company makes no commitment as to proceeds or timing, but its Section 3 obligations are not conditioned on ATM results.
- Warrant Exchange
- After 1-for-30 reverse split on August 3, 2026, warrants are for 8,310,250 shares at $1.90 exercise price.
- Warrants are amended to permit cashless exchange using an Exchange Ratio of 0.5415.
- A total of 4,500,000 ordinary shares are issuable upon cashless exchange of warrants.
- Exchange Shares are delivered via DTC without restrictive legend by the first trading day after exchange notice.
- Cashless exchange may be initiated by Holder on or after September 25, 2026.
- Exchange Shares allocated: AIMF 3,510,000 shares; AEMF 990,000 shares.
- No cash consideration is payable by Holder for cashless exchange.
- Exchange Shares issued under Securities Act Section 3(a)(9); Rule 144 holding period tacks.
- Company must deliver irrevocable transfer agent instructions for Exchange Shares within one trading day.
- Company counsel must deliver legal opinion for Exchange Shares to transfer agent.
- Company will not require Holder documents for Exchange Shares beyond exchange notice.
- Holder entitled to daily cash payment and Buy-In remedies for failed Exchange Share delivery.
- Exchange Shares, when issued, will be duly authorized, validly issued, fully paid and non-assessable, free of any liens, preemptive rights, transfer restrictions (other than under applicable securities laws) or restrictive legends, and approved for listing on Nasdaq.
- The Company has reserved, and will maintain, a sufficient number of authorized but unissued ordinary shares to issue all of the Exchange Shares.
- Warrant exchange is subject to ownership limits and specified adjustments; delivery of exchange shares cancels exchanged warrants, eliminating anti-dilution and price-adjustment provisions.
- Volume Limitation
- Holder agrees to a volume limitation of 15% of daily Nasdaq trading volume for Exchange Shares or Note conversion shares.
- Volume limitation terminates upon uncured Company defaults or Nasdaq trading suspension for over five days.
- Volume limitation period is defined as the "Leak-Out Period."
- Volume limitation excludes pledges, affiliate transfers, and private transactions not on open market.
- Volume Limitation terminates upon Company's failure to make any ATM Payment or deliver any Exchange Shares when due, uncured for ten (5) business days.
- Volume Limitation terminates if Company fails to make any ATM Payment or deliver any Exchange Shares when due, uncured for ten (5) business days.
- Volume Limitation terminates upon any other material breach by Company of this Agreement not cured within 5 business days.
- Volume Limitation terminates upon any event of default under the Note uncured beyond applicable cure period.
- Volume Limitation terminates upon suspension, delisting or halting of trading of ordinary shares on Nasdaq for more than five Trading Days.
- Inadvertent sale exceeding Volume Limitation is not breach if Holder reduces sales on following Trading Day by the excess amount.
- Volume Limitation does not apply to Holder's sales of ordinary shares prior to the Effective Date.
- Collateral and Security
- Digital Assets or AI Infrastructure Investments acquired with ATM proceeds constitute Collateral under Section 7(b)(ix) of the Note and Sections 4.13 and 4.17 of the SPA.
- Any Digital Assets or AI Infrastructure Investments acquired with ATM proceeds constitute Collateral under Section 7(b)(ix) of the Note and Sections 4.13 and 4.17 of the SPA, subject to release upon payment of the Agreed Payment Amount.
- Nothing in the Agreement releases, subordinates or otherwise affects the Collateral, the Security Agreement, the Account Control Agreement or the rights of the Agent thereunder.
- Shareholder Approval and Nasdaq
- If shareholder approval is required for Exchange Shares, the Company must obtain it within 60 days after the Effective Date, and the ATM consent and waiver in Section 1 is suspended until obtained.
- Company submitted a "Cayman Home Country Practice" letter to Nasdaq on September 30, 2026, and believes the agreement will not trigger Nasdaq Rule 5635(d).
- If Nasdaq applies Rule 5635(d), the parties will discuss and execute in good faith the most efficient way to issue shares beyond the 20% as diligently as it can.
- Company represents no shareholder, Nasdaq or other approval is required for amendment of Existing Warrants or issuance of Exchange Shares.
- Cleansing 6-K and Information
- Company must furnish a Cleansing 6-K by 9:00 a.m. New York time on the first business day after the Effective Date.
- Upon furnishing of the Cleansing 6-K, the Holder will not be in possession of any material, non-public information concerning the Company or its subsidiaries received from the Company or its representatives.
- From and after the Effective Date, the Company shall not, and shall cause its officers, directors, agents and representatives not to, provide the Holder with any material, non-public information concerning the Company without the Holder's prior written consent.
- Company shall not publicly disclose the name of the Holder, any Holder Fund or any of their affiliates, or include such names in any filing with the SEC or any regulatory agency or Nasdaq, without the Holder's prior written consent, except in the Cleansing 6-K in the form reasonably approved by the Holder and as otherwise required by applicable law.
- Representations and Covenants
- Company represents it obtained all consents for ATM, including for August 2026 offering.
- Company represents no other person is entitled to undisclosed ATM consideration or rights.
- Company represents it is not, and has never been, a "shell company" as defined in Rule 144(i) under the Securities Act.
- Company shall remain current in its reporting obligations under the Securities Exchange Act of 1934 until the Holder has sold or otherwise disposed of all Exchange Shares.
- The Company has filed all reports required to be filed by it under the Securities Exchange Act of 1934 during the preceding twelve months.
- Miscellaneous
- Agreement dated October 2, 2026, announced October 5, 2026, named "ATM Consent, Note Repayment and Warrant Exchange Agreement".
- Counterparties are Anson Investments Master Fund L.P. and Anson East Master Fund L.P., with AIMF as collateral agent.
- Agreement's effective date is September 25, 2026.
- Each Holder Fund's obligations under the Agreement are several and not joint, and nothing in the Agreement shall be deemed to constitute the Holder Funds as a partnership, association or "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934.
- The Agreement is a Transaction Document for purposes of the SPA and the Note.
- Disputes under Section 3 may at the Holder's election be brought in accordance with Section 13 of the Existing Warrants.
- SPA Sections 5.10 (including prevailing-party fee provision) and 5.23 apply to this Agreement mutatis mutandis.
- Holder may assign its rights under this Agreement to any transferee of the Note or Existing Warrants.
All 65 details
- Agreement dated October 2, 2026, announced October 5, 2026, named "ATM Consent, Note Repayment and Warrant Exchange Agreement".
- Counterparties are Anson Investments Master Fund L.P. and Anson East Master Fund L.P., with AIMF as collateral agent.
- Senior Secured Convertible Notes are due July 12, 2027.
- ATM consent period is from week of September 28, 2026, through March 31, 2027.
- Holder waives Variable Rate Transaction prohibition (SPA Section 4.12(b)) and participation right (SPA Section 4.19) for ATM sales.
- ATM consent is suspended if Company materially defaults on payment or delivery obligations for five business days.
- Company must pay Holder 20% of net ATM proceeds (after commissions/expenses) within three business days of settlement.
- Holder applies ATM payments first to accrued interest and late fees, then to principal.
- Unpaid ATM payments bear 8% annual interest from the third business day after the due date.
- After 1-for-30 reverse split on August 3, 2026, warrants are for 8,310,250 shares at $1.90 exercise price.
- Warrants are amended to permit cashless exchange using an Exchange Ratio of 0.5415.
- A total of 4,500,000 ordinary shares are issuable upon cashless exchange of warrants.
- Exchange Shares are delivered via DTC without restrictive legend by the first trading day after exchange notice.
- Holder agrees to a volume limitation of 15% of daily Nasdaq trading volume for Exchange Shares or Note conversion shares.
- Volume limitation terminates upon uncured Company defaults or Nasdaq trading suspension for over five days.
- Once Note principal falls below $500,000, the Variable Rate Transaction prohibition in Section 4.12 is waived.
- Participation rights under Section 4.19 continue for 10 months after Note principal falls below $500,000.
- Digital Assets or AI Infrastructure Investments acquired with ATM proceeds constitute Collateral under Section 7(b)(ix) of the Note and Sections 4.13 and 4.17 of the SPA.
- If shareholder approval is required for Exchange Shares, the Company must obtain it within 60 days after the Effective Date, and the ATM consent and waiver in Section 1 is suspended until obtained.
- Company must furnish a Cleansing 6-K by 9:00 a.m. New York time on the first business day after the Effective Date.
- Agreement's effective date is September 25, 2026.
- Company represents it obtained all consents for ATM, including for August 2026 offering.
- Company represents no other person is entitled to undisclosed ATM consideration or rights.
- ATM payments are allocated pro rata between Holder Funds based on Note principal.
- ATM payments must include a statement of shares sold, proceeds, commissions, and expenses.
- Cashless exchange may be initiated by Holder on or after September 25, 2026.
- Exchange Shares allocated: AIMF 3,510,000 shares; AEMF 990,000 shares.
- No cash consideration is payable by Holder for cashless exchange.
- Exchange Shares issued under Securities Act Section 3(a)(9); Rule 144 holding period tacks.
- Company must deliver irrevocable transfer agent instructions for Exchange Shares within one trading day.
- Company counsel must deliver legal opinion for Exchange Shares to transfer agent.
- Company will not require Holder documents for Exchange Shares beyond exchange notice.
- Holder entitled to daily cash payment and Buy-In remedies for failed Exchange Share delivery.
- Volume limitation period is defined as the "Leak-Out Period."
- Volume limitation excludes pledges, affiliate transfers, and private transactions not on open market.
- Volume Limitation terminates upon Company's failure to make any ATM Payment or deliver any Exchange Shares when due, uncured for ten (5) business days.
- ATM Payments are in addition to, and not in substitution for, Holder's rights under Section 9 of the Note, which continue to apply to any private placement financing, Change of Control Transaction or other event described therein.
- Any Digital Assets or AI Infrastructure Investments acquired with ATM proceeds constitute Collateral under Section 7(b)(ix) of the Note and Sections 4.13 and 4.17 of the SPA, subject to release upon payment of the Agreed Payment Amount.
- Nothing in the Agreement releases, subordinates or otherwise affects the Collateral, the Security Agreement, the Account Control Agreement or the rights of the Agent thereunder.
- Company submitted a "Cayman Home Country Practice" letter to Nasdaq on September 30, 2026, and believes the agreement will not trigger Nasdaq Rule 5635(d).
- If Nasdaq applies Rule 5635(d), the parties will discuss and execute in good faith the most efficient way to issue shares beyond the 20% as diligently as it can.
- Exchange Shares, when issued, will be duly authorized, validly issued, fully paid and non-assessable, free of any liens, preemptive rights, transfer restrictions (other than under applicable securities laws) or restrictive legends, and approved for listing on Nasdaq.
- Company represents it is not, and has never been, a "shell company" as defined in Rule 144(i) under the Securities Act.
- Company shall remain current in its reporting obligations under the Securities Exchange Act of 1934 until the Holder has sold or otherwise disposed of all Exchange Shares.
- Upon furnishing of the Cleansing 6-K, the Holder will not be in possession of any material, non-public information concerning the Company or its subsidiaries received from the Company or its representatives.
- From and after the Effective Date, the Company shall not, and shall cause its officers, directors, agents and representatives not to, provide the Holder with any material, non-public information concerning the Company without the Holder's prior written consent.
- Company shall not publicly disclose the name of the Holder, any Holder Fund or any of their affiliates, or include such names in any filing with the SEC or any regulatory agency or Nasdaq, without the Holder's prior written consent, except in the Cleansing 6-K in the form reasonably approved by the Holder and as otherwise required by applicable law.
- Each Holder Fund's obligations under the Agreement are several and not joint, and nothing in the Agreement shall be deemed to constitute the Holder Funds as a partnership, association or "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934.
- The Agreement is a Transaction Document for purposes of the SPA and the Note.
- Disputes under Section 3 may at the Holder's election be brought in accordance with Section 13 of the Existing Warrants.
- Cashless exchange provides no cash proceeds to Company and will dilute existing shareholders.
- Volume Limitation terminates if Company fails to make any ATM Payment or deliver any Exchange Shares when due, uncured for ten (5) business days.
- Volume Limitation terminates upon any other material breach by Company of this Agreement not cured within 5 business days.
- Volume Limitation terminates upon any event of default under the Note uncured beyond applicable cure period.
- Volume Limitation terminates upon suspension, delisting or halting of trading of ordinary shares on Nasdaq for more than five Trading Days.
- Inadvertent sale exceeding Volume Limitation is not breach if Holder reduces sales on following Trading Day by the excess amount.
- Volume Limitation does not apply to Holder's sales of ordinary shares prior to the Effective Date.
- Company represents no shareholder, Nasdaq or other approval is required for amendment of Existing Warrants or issuance of Exchange Shares.
- SPA Sections 5.10 (including prevailing-party fee provision) and 5.23 apply to this Agreement mutatis mutandis.
- Holder may assign its rights under this Agreement to any transferee of the Note or Existing Warrants.
- The ATM offering is conducted pursuant to the Company's effective Form F-3 registration statement and a sales agreement with its sales agent.
- The Company has reserved, and will maintain, a sufficient number of authorized but unissued ordinary shares to issue all of the Exchange Shares.
- The Company has filed all reports required to be filed by it under the Securities Exchange Act of 1934 during the preceding twelve months.
- The Holder acknowledges the ATM may be delayed, suspended or terminated for legal, market or operational reasons, and the Company makes no commitment as to proceeds or timing, but its Section 3 obligations are not conditioned on ATM results.
- Warrant exchange is subject to ownership limits and specified adjustments; delivery of exchange shares cancels exchanged warrants, eliminating anti-dilution and price-adjustment provisions.
- Note Conversion Terms
At the time of this announcement, NXAT was trading at $0.95 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $0.80 to $99.90. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.